Unichem Pharmaceuticals (USA), Inc. Recalls

3 recalls found for Unichem Pharmaceuticals (USA), Inc.. Check if any of your products are affected.

HIGHFDA DRUG

Unichem Pharmaceuticals Recalls Bisoprolol Tablets Over Impurity Risk

Unichem Pharmaceuticals recalled Bisoprolol Fumarate and Hydrochlorothiazide tablets on January 21, 2026. The recall affects tablets that do not meet impurity specifications for N-Nitroso Bisoprolol. Consumers should stop using the product and contact their healthcare provider immediately.

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
cGMP Deviations:
Read more
HIGHFDA DRUG

Unichem Pharmaceuticals Recalls Doxazosin Tablets Over ID Error

Unichem Pharmaceuticals recalled 60,000 bottles of Doxazosin Tablets on January 21, 2026. The tablets were imprinted with the wrong ID, posing a serious risk to consumers. Healthcare providers and users should stop using the product immediately.

DOXAZOSIN MESYLATE
Tablets/Capsules Imprinted
Read more
HIGHFDA DRUG

Unichem Pharmaceuticals Recalls Cyclobenzaprine Tablets Due to Labeling Error

Unichem Pharmaceuticals recalled 230 bottles of Cyclobenzaprine Hydrochloride Tablets on August 27, 2025. The recall stems from a labeling mix-up with Meloxicam tablets, which could lead to serious health risks. Consumers should stop using the product immediately and contact their healthcare provider.

CYCLOBENZAPRINE HYDROCHLORIDE
Labeling: Label
Read more